Five-Year Survival Outcomes with Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227
- Brahmer, J.R.
- Lee, J.-S.
- Ciuleanu, T.-E.
- Bernabe Caro, R.
- Nishio, M.
- Urban, L.
- Audigier-Valette, C.
- Lupinacci, L.
- Sangha, R.
- Pluzanski, A.
- Burgers, J.
- Mahave, M.
- Ahmed, S.
- Schoenfeld, A.J.
- Paz-Ares, L.G.
- Reck, M.
- Borghaei, H.
- O'Byrne, K.J.
- Gupta, R.G.
- Bushong, J.
- Li, L.
- Blum, S.I.
- Eccles, L.J.
- Ramalingam, S.S.
ISSN: 1527-7755, 0732-183X
Datum der Publikation: 2023
Ausgabe: 41
Nummer: 6
Seiten: 1200-1212
Art: Artikel